Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma.

about

Small Airway Disease in Patients with Chronic Obstructive Pulmonary Disease Next generation beta adrenoreceptor agonists for the treatment of asthma.

P2860

Q41658426-60DAEDC7-8B38-4A5B-88E8-ADB88551747F Q47777308-9939CC37-F18B-486F-A01C-BAF925E7FE87

P2860

Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma.

Item

http://www.wikidata.org/entity/Q38759118

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Inhaled beclometasone dipropio ...... n for the treatment of asthma.

@en

type

Item

label

Inhaled beclometasone dipropio ...... n for the treatment of asthma.

@en

prefLabel

Inhaled beclometasone dipropio ...... n for the treatment of asthma.

@en

P1476

Inhaled beclometasone dipropio ...... n for the treatment of asthma.

@en

P2093

Alfredo Chetta

http://www.w3.org/2001/XMLSchema#string

Andrea Zanini

http://www.w3.org/2001/XMLSchema#string

Ernesto Crisafulli

http://www.w3.org/2001/XMLSchema#string

Gianluigi Poli

http://www.w3.org/2001/XMLSchema#string

Giovanna Pisi

http://www.w3.org/2001/XMLSchema#string

Mario Scuri

http://www.w3.org/2001/XMLSchema#string

Patrizia Pignatti

http://www.w3.org/2001/XMLSchema#string

P2860

Pathogenesis of small airways in asthma

Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma

Comparing usability of NEXThaler(®) with other inhaled corticosteroid/long-acting β2-agonist fixed combination dry powder inhalers in asthma patients.

Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology.

Co-deposition of salmeterol and fluticasone propionate by a combination inhaler.

Patient perspectives in the management of asthma: improving patient outcomes through critical selection of treatment options

Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma.

Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial

Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids.

P304

481-490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17476348.2016.1161508

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26938578

http://www.w3.org/2001/XMLSchema#string

P921

asthma

Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma.

about

P2860

P2860

Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921